ZURICH–Novartis AG said Sunday that the head of its cancer business had left the company for a new job, creating a vacancy at the top of one of its most important franchises. . Basel-based Novartis said Hervé Hoppenot, who had been president of Novartis Oncology since 2010, would be replaced on an interim basis by Alessandro Riva, who is in charge of the unit's development and medical affairs. . A...
  